Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Post by BioTeckon Apr 09, 2021 3:12pm
174 Views
Post# 32968150

No sense arguing

No sense arguingRed, you obviously are happy with management. Others are not. That is likely not going to change. Sell and move on would be an option if the volume was there. We'd sink this stock to 20 cents if we all decided to sell. So since that isn't an option the only other option we have is to do something because what is currently happening is clearly not good enough for a company that allegedly has a cure for diabetes.

For me personally what management could do to make me change my mind:

1. Update on conformal coating tech. What's happening with it, who is doing what and where are we with it? Update on Age-x as well similar to above.

2. Update on patient numbers 2-5 and and update on why patients 6 &7 are 4 months late (don't blame covid).

3. What is going on with Hemo?  What has been done since the Horizons project ended and what progress has been made moving this forward.

4. Why do we have to wait for presentations to get news about thyroid. Why can't they put out updates as they happen instead of keeping investors in the dark.

5. What kind of deal are you looking to make? Why is it taking so long and what is the reason you haven't been able to make any deals? What makes everybody walk?


Red, unless you know the answers to these questions, I'm surprised you are OK with the silence and the only news releases being PP news and conference presentations. 

<< Previous
Bullboard Posts
Next >>